Inhibitor Discovery of Full-Length New Delhi Metallo-β-Lactamase-1 (NDM-1)

New Delhi metallo-β-lactmase-1 (NDM-1) has recently attracted extensive attention for its biological activities to catalyze the hydrolysis of almost all of β-lactam antibiotics. To study the catalytic property of NDM-1, the steady-kinetic parameters of NDM-1 toward several kinds of β-lactam antibiotics have been detected. It could effectively hydrolyze most β-lactams (k cat/K m ratios between 0.03 to 1.28 µmol−1.s−1), except aztreonam. We also found that thiophene-carboxylic acid derivatives could inhibit NDM-1 and have shown synergistic antibacterial activity in combination with meropenem. Flexible docking and quantum mechanics (QM) study revealed electrostatic interactions between the sulfur atom of thiophene-carboxylic acid derivatives and the zinc ion of NDM-1, along with hydrogen bond between inhibitor and His189 of NDM-1. The interaction models proposed here can be used in rational design of NDM-1 inhibitors.

[1]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[2]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[3]  Hua Guo,et al.  Characterization of purified New Delhi metallo-β-lactamase-1. , 2011, Biochemistry.

[4]  D. Paterson,et al.  Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. , 2012, International journal of antimicrobial agents.

[5]  B. Leiting,et al.  Inhibition of IMP-1 metallo-beta-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives. , 1999, FEMS microbiology letters.

[6]  J. Meulenbelt,et al.  Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration , 2000, Critical care medicine.

[7]  Moreno Galleni,et al.  Standard Numbering Scheme for Class B β-Lactamases , 2001, Antimicrobial Agents and Chemotherapy.

[8]  R. Ambler,et al.  The structure of beta-lactamases. , 1980, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[9]  Y. Arakawa,et al.  SMB-1, a Novel Subclass B3 Metallo-β-Lactamase, Associated with ISCR1 and a Class 1 Integron, from a Carbapenem-Resistant Serratia marcescens Clinical Isolate , 2011, Antimicrobial Agents and Chemotherapy.

[10]  G. Cornaglia,et al.  New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  R. Moellering.  NDM-1--a cause for worldwide concern. , 2010, The New England journal of medicine.

[12]  Quan Hao,et al.  Crystal structure of NDM‐1 reveals a common β‐lactam hydrolysis mechanism , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  P. Hohenberg,et al.  Inhomogeneous Electron Gas , 1964 .

[14]  Kevin E. Riley,et al.  Critical Assessment of the Performance of Density Functional Methods for Several Atomic and Molecular Properties. , 2007, Journal of chemical theory and computation.

[15]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[16]  Lisa Yan,et al.  Fully Automated Molecular Mechanics Based Induced Fit Protein—Ligand Docking Method. , 2009 .

[17]  Gyorgy Babnigg,et al.  Structure of Apo- and Monometalated Forms of NDM-1—A Highly Potent Carbapenem-Hydrolyzing Metallo-β-Lactamase , 2011, PloS one.

[18]  L. Poirel,et al.  Emergence of nosocomial New Delhi metallo-β-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait. , 2012, International journal of antimicrobial agents.

[19]  Honggang Zhou,et al.  A structural view of the antibiotic degradation enzyme NDM-1 from a superbug , 2011, Protein & Cell.

[20]  M. Levy.  Universal variational functionals of electron densities, first-order density matrices, and natural spin-orbitals and solution of the v-representability problem. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[22]  M. Zhang,et al.  Effective antimicrobial activity of Cbf‐K16 and Cbf‐A7A13 against NDM‐1‐carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro , 2013, Journal of peptide science : an official publication of the European Peptide Society.

[23]  R. Ballardini,et al.  Experimental investigation of highly exergonic outer-sphere electron-transfer reactions , 1984 .

[24]  P. Nordmann,et al.  Emergence of Metallo-β-Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in Australia , 2010, Antimicrobial Agents and Chemotherapy.

[25]  J. Frère,et al.  Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-β-Lactamase IMP-1 Produced byEscherichia coli , 1999, Antimicrobial Agents and Chemotherapy.

[26]  S. Teague.  Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.

[27]  A. Becke.  A multicenter numerical integration scheme for polyatomic molecules , 1988 .

[28]  Michael W Crowder,et al.  Mechanistic and spectroscopic studies of metallo-β-lactamase NDM-1. , 2012, Biochemistry.

[29]  Lochana C. Menikarachchi,et al.  QM/MM approaches in medicinal chemistry research. , 2010, Current topics in medicinal chemistry.

[30]  N. Khardori.  NDM-1 — A Cause for Worldwide Concern , 2011 .

[31]  Carine Bebrone,et al.  Update of the Standard Numbering Scheme for Class B β-Lactamases , 2004, Antimicrobial Agents and Chemotherapy.

[32]  J. Toney,et al.  Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1. , 2005, FEMS microbiology letters.

[33]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[34]  S. C. Rogers,et al.  QUASI: A general purpose implementation of the QM/MM approach and its application to problems in catalysis , 2003 .

[35]  G. Cornaglia,et al.  Metallo-β-lactamases: a last frontier for β-lactams? , 2011, The Lancet. Infectious diseases.

[36]  Clinical,et al.  Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement , 2008 .